LGM
APLT

Logos Global Management’s Applied Therapeutics APLT Stock Holding History

Logos Global Management’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-600,000
Closed -$2.66M – 58
2024
Q2 		$2.66M Sell
600,000
-750,000
-56% -$3.55M 0.21% 52
2024
Q1 		$8.98M Sell
1,350,000
-310,000
-19% -$1.39M 0.73% 37
2023
Q4 		$5.56M Buy
+1,660,000
New +$4.13M 0.52% 40
2020
Q3 		– Sell
-12,600
Closed -$455K – 48
2020
Q2 		$455K Buy
+12,600
New +$527K 0.09% 46

Other funds holding APLT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Logos Global Management's APLT Position: Q3 2024 in Review

Logos Global Management sold out of Applied Therapeutics (APLT) in Q3 2024, closing a stake of 600,000 shares — an estimated $2.66M sold.

Logos Global Management first reported a position in APLT in Q2 2020 and held it in 4 quarters. The position peaked at $8.98M in Q1 2024. 126 funds tracked by Wall St. Rank hold APLT as of Q3 2024.

  • Logos Global Management reported no remaining Applied Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Logos Global Management sold 600,000 Applied Therapeutics shares in Q3 2024, an estimated $2.66M.
  • Logos Global Management first reported a position in Applied Therapeutics in Q2 2020 and held it in 4 quarters.
  • Logos Global Management's Applied Therapeutics position peaked at $8.98M in Q1 2024.
  • 126 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2024.

Based on Logos Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.